About IQA

The mission of the IQA program, is to improve national/international standardization and overall performance of immunology laboratories participating in the National Institute of Allergy and Infectious Diseases Division of AIDS (NIAID) sponsored clinical trials and research programs. An additional component of the IQA is to help develop new technology and laboratory assays that may be useful in monitoring patients with HIV infection and evaluate potential HIV vaccines, as well as adding new insights into the pathogenesis of disease progression.

Contact Information

Raul Louzao, IQA Program Manager
Immunology Quality Assessment Program
Duke Human Vaccine Institute
RTP/IVQAC Lab 3rd FL.
27 Alexandria Way
Durham, NC 27703